Research Topics
Species | Ashley GrossmanSummaryAffiliation: Queen Mary Country: UK Publications
| Collaborators
|
Detail Information
Publications
Imaging in Cushing's syndromeAnju Sahdev
Department of Diagnostic Imaging, St Bartholomew s Hospital, London, UK
Arq Bras Endocrinol Metabol 51:1319-28. 2007..MRI is used for characterising adrenal adenomas, problem solving in difficult cases and for detecting ACTH-secreting pituitary adenomas...
Clinical Review#: The diagnosis and management of central hypoadrenalismAshley B Grossman
Barts and the London School of Medicine, London, United Kingdom
J Clin Endocrinol Metab 95:4855-63. 2010..It is essential to perform validated diagnostic procedures and manage such patients with clear objectives and based on well-established replacement programs...
Commentary: imaging of islet-cell tumoursAshley B Grossman
Department of Endocrinology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK
Best Pract Res Clin Endocrinol Metab 19:241-3. 2005
Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus?Ashley Grossman
Department of Endocrinology, St Bartholomew s Hospital, West Smithfield, London, EC1A 7BE, UK, and Department of Medicine, University of Toronto, Ontario, Canada
Ann N Y Acad Sci 1073:332-47. 2006..This article summarizes the discussion and recommendations derived from that session...
Cushing's syndrome caused by an occult source: difficulties in diagnosis and managementAshley B Grossman
Centre for Endocrinology, St Bartholomew s Hospital, Bart s and The London Medical School, Queen Mary, University of London, UK
Nat Clin Pract Endocrinol Metab 2:642-7. 2006..She did not take tobacco, recreational drugs or alcohol. Upon physical examination she was grossly Cushingoid with florid clinical manifestations...
Akting and cycling: a tale of the pituitaryAshley B Grossman
Department of Endocrinology, St Bartholomew s Hospital, London, UK
Horm Res 62:117-23. 2004....
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptorBlerina Kola
Departments of Endocrinology and Histopatholgy, St Bartholomew s Hospital and National Institute of Neurology and Neurosurgery, London, UK
Clin Endocrinol (Oxf) 59:328-38. 2003..We hypothesized that the physiological IGF-I/GH negative feedback loop may be reset in somatotroph adenomas, specifically in terms of the level of expression of these receptors or mutations of the GH receptor (GH-R) in such tumours...
The molecular biology of pituitary tumors: a personal perspectiveAshley B Grossman
Department of Endocrinology, Centre for Endocrinology, St Bartholomew s Hospital, West Smithfield, London EC1A 7BE, UK
Pituitary 12:265-70. 2009..These pathways share a common root in the tyrosine kinase receptor, and a change to these receptors or their relationship to membrane matrix-related proteins may be an early event in tumorigenesis...
Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's diseaseHelen L Storr
Department of Endocrinology, St Bartholomew's Hospital, London, UK
Eur J Endocrinol 152:825-33. 2005....
The role of somatostatin analogues in the treatment of neuroendocrine tumoursSimona Grozinsky-Glasberg
Department of Endocrinology, William Harvey Research Institute, Barts and The London, Queen Mary School of Medicine, University of London, London, UK
Mol Cell Endocrinol 286:238-50. 2008..Development of new somatostatin analogues and new drug combination therapies should further improve the clinical management of these patients...
Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesityMaria Gueorguiev
Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK
Obesity (Silver Spring) 17:745-54. 2009....
A mutation and expression analysis of the oncogene BRAF in pituitary adenomasIain Ewing
Department of Endocrinology, Barts and the London School of Medicine, Queen Mary University of London, UK
Clin Endocrinol (Oxf) 66:348-52. 2007..We speculated that this same gene may be either mutated at this site, or overexpressed, in pituitary adenomas...
Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumorsMichel Procopiou
Department of Endocrinology, St Bartholomew s Hospital, West Smithfield, London EC1A7BE, UK
Eur J Endocrinol 161:131-40. 2009..To define the test characteristics of an enzyme immunoassay (EIA) for plasma-free metanephrines (metanephrine and normetanephrine) in the diagnosis of pheochromocytoma and paraganglioma...
Diagnosis and treatment of Cushing's disease in childrenMartin O Savage
Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Barts and the Royal London NHS Trust, London, UK
Endocr Dev 17:134-45. 2010..The management of paediatric CD patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptorMichelle N Emery
Department of Endocrinology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK
Clin Endocrinol (Oxf) 65:389-95. 2006..CONCLUSIONS :Our data suggest that the antiproliferative action of rosiglitazone is probably not via PPAR-gamma...
Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumoursUmasuthan Srirangalingam
Department of Endocrinology, St Bartholomew s Hospital, West Smithfield, London EC1A 7BE, UK
Endocr Relat Cancer 16:515-25. 2009..VHL-related tumours tend to be adrenal phaeochromocytomas, frequently bilateral and associated with a milder phenotype...
The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-upAndrea M Isidori
Department of Endocrinology, St. Bartholomew's Hospital, London EC1A 7BE, United Kingdom
J Clin Endocrinol Metab 91:371-7. 2006..These cases require a prolonged follow-up, review, and repetition of diagnostic tests and scans...
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patientsAmar Agha
William Harvey Research Institute, Queen Mary University of London, London, UK
Clin Endocrinol (Oxf) 66:72-7. 2007..The effect of GH replacement on thyroid function in hypopituitary patients has hitherto been studied in small groups of children and adults with conflicting results...
Work-up and management of paediatric Cushing's syndromeMartin O Savage
Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London, UK
Curr Opin Endocrinol Diabetes Obes 15:346-51. 2008..A protocol for investigation of the child with suspected Cushing's syndrome is presented followed by principles of management...
Diagnosis and treatment of pediatric Cushing's diseaseMartin O Savage
Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK
Pituitary 10:365-71. 2007..The management of pediatric CD patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomasChrysanthia A Leontiou
Department of Endocrinology, Barts and the London School of Medicine, London, United Kingdom
J Clin Endocrinol Metab 93:2390-401. 2008..Mutations have been identified in the aryl hydrocarbon receptor-interacting protein (AIP) gene in familial isolated pituitary adenomas (FIPA). It is not clear, however, how this molecular chaperone is involved in tumorigenesis...
Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriersUmasuthan Srirangalingam
Department of Endocrinology, St Bartholomew s Hospital, West Smithfield, London, UK
Clin Endocrinol (Oxf) 69:587-96. 2008..The aim of this study was to describe the clinical manifestations of subjects with SDH-B gene mutations...
Advances in the management of paediatric Cushing's diseaseMartin O Savage
Department of Endocrinology, Barts and the London School of Medicine and Dentistry, London, UK
Horm Res 69:327-33. 2008..The management of paediatric CD patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
Pediatric Cushing's syndrome: clinical features, diagnosis, and treatmentLi F Chan
Department of Endocrinology, William Harvey Research Institute, St Bartholomew s and the Royal London School of Medicine and Dentistry
Arq Bras Endocrinol Metabol 51:1261-71. 2007..This article will aim to provide an overall view of pediatric CS highlighting some of the differences between adult and pediatric CS...
Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatmentHelen L Storr
Department of Endocrinology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London EC1A 7BE, United Kingdom
J Clin Endocrinol Metab 88:34-7. 2003..GH deficiency occurred in 86% patients. Long-term follow-up suggests some recovery of GH secretion and preservation of other anterior pituitary function...
A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese childrenMarta Korbonits
Department of Endocrinology, St Bartholomew s Hospital, London EC1A 7BE, United Kingdom
J Clin Endocrinol Metab 87:4005-8. 2002..These data suggest that variations in the ghrelin gene contribute to obesity in children and may modulate glucose-induced insulin secretion...
Role of regulatory factors in pituitary tumour formationMarta Korbonits
Department of Endocrinology, St Bartholomew s Hospital, London, UK
Front Horm Res 32:63-95. 2004....
Ghrelin--a hormone with multiple functionsMarta Korbonits
Department of Endocrinology, St Bartholomew s Hospital, London EC1A 7BE, UK
Front Neuroendocrinol 25:27-68. 2004..Increasing data link ghrelin to the overall control of energy use and flow in situations where there is a limitation of energy sources and ghrelin appears to play a pivotal role in energy homeostasis...
CT and MR imaging of the adrenal glands in ACTH-independent cushing syndromeAndrea G Rockall
Department of Academic Radiology, St Bartholomew s Hospital, Dominion House, St Bartholomew s Close, London EC1A 7ED, England
Radiographics 24:435-52. 2004..Familiarity with the range of imaging appearances of the adrenal glands in primary adrenal Cushing syndrome may help establish the underlying diagnosis...
The expression of the F-box protein Skp2 is negatively associated with p27 expression in human pituitary tumorsMadalina Musat
Department of Endocrinology, St Bartholomew s Hospital, London EC1A 7BE, UK
Pituitary 5:235-42. 2002..Our data suggest that increased p27 degradation through the ubiquitin-proteasome pathway could be regulated in pituitary tumors by changes in Skp2 expression, although other factors probably also play a role...
The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humansSharmilee Gnanapavan
Department of Endocrinology, St Bartholomew s and The Royal London Hospital, London ECIA 7BE, UK
J Clin Endocrinol Metab 87:2988. 2002..These data suggest that ghrelin might have widespread physiological effects via different, partly unidentified, subtypes of the GHS-R in endocrine and non-endocrine tissues...
Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancerDorota Dworakowska
Department of Endocrinology and Internal Medicine, Medical University of Gdansk, Poland
Lung Cancer 66:127-33. 2009..04). This study demonstrates that joint analysis of several factors involved in apoptosis, proliferation and cell cycle regulation, but not AI alone, might provide additional prognostic information in NSCLC patients...
The diagnosis and medical management of advanced neuroendocrine tumorsGregory A Kaltsas
Department of Endocrinology, St Bartholomew's Hospital, London EC1A 7BE, United Kingdom
Endocr Rev 25:458-511. 2004..Maintenance of the quality of life should be a priority, particularly because patients with disseminated disease may experience prolonged survival...
The expression of ghrelin O-acyltransferase (GOAT) in human tissuesChung Thong Lim
Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom
Endocr J 58:707-10. 2011..Identification of GOAT expression in various tissues support the concept that in addition to the important endocrine effect of acylated ghrelin, the paracrine effects of locally synthetised and acylated ghrelin may be important...
Androgen- and estrogen-secreting adrenal cancersDominic Cavlan
Department of Endocrinology, Barts and The London NHS Trust, London, UK
Semin Oncol 37:638-48. 2010..The most reliable indicator of malignancy in these tumors remains the presence of metastases. Treatment is essentially surgical, although the role of mitotane is one undergoing evaluation...
Examining the candidacy of ghrelin as a gene responsible for variation in adult stature in a United Kingdom population with type 2 diabetesMaria Gueorguiev
Reader in Endocrine Research, Department of Endocrinology, Room 114C, John Vane Science Centre, Barts and the London Medical School, Charterhouse Square, London, UK
J Clin Endocrinol Metab 92:2201-4. 2007..Recently, a quantitative trait locus for stature was reported on chromosome 3p26 in patients with type 2 diabetes...
Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomasDamian G Morris
Department of Endocrinology, St Bartholomew s Hospital, London EC1A 7BE, United Kingdom
J Clin Endocrinol Metab 88:6080-7. 2003....
Protein western array analysis in human pituitary tumours: insights and limitationsAntônio Ribeiro-Oliveira
Department of Endocrinology, Barts and the London School of Medicine and Dentistry, London EC1M 6BQ, UK
Endocr Relat Cancer 15:1099-114. 2008..Protein expression analysis of pituitary samples disclosed both novel proteins and putative protein candidates for pituitary tumorigenesis, though validation using conventional techniques are necessary to confirm the protein array data...
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndromeBlerina Kola
Centre for Endocrinology, John Vane Science Centre, Barts and the London School of Medicine and Dentistry, London EC1M 6BQ, United Kingdom
J Clin Endocrinol Metab 93:4969-73. 2008..In the current study, we demonstrate the effect of high glucocorticoid levels on AMPK activity of human adipose tissue samples from patients with Cushing's syndrome...
Expanding role of AMPK in endocrinologyBlerina Kola
Department of Endocrinology, Barts and The London, Queen Mary's School of Medicine and Dentistry, University of London, London, EC1M 6BQ, UK
Trends Endocrinol Metab 17:205-15. 2006..Recent studies have illustrated the interaction between hormones and AMPK, and highlighted AMPK as a potential target for the development of tissue-specific AMPK modulators in the treatment of obesity and the metabolic syndrome...
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumoursErika Hubina
Department of Endocrinology, William Harvey Research Institute, Barts and the London Medical School, Queen Mary College, Charterhouse Square, London EC1M 6BQ, UK
Eur J Endocrinol 155:371-9. 2006..More potent and broader-spectrum SST analogues are likely to play an increasing role in the treatment of tumours, where the MAP kinase pathway is overactivated...
Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumoursGregory A Kaltsas
Department of Endocrinology, St. Bartholomew's Hospital, London EC1A 7BE, UK
Clin Endocrinol (Oxf) 57:443-8. 2002..Relative mRNA expression was not decreased in any of the sporadic pituitary tumour samples. The present data thus do not suggest a major role for the PRKAR1A tumour suppressor gene in sporadic GH-secreting or other pituitary tumours...
Imaging in covert ectopic ACTH secretion: a CT pictorial reviewPaul A Sookur
Department of Academic Radiology, Dominion House, St Bartholomew s Hospital, West Smithfield, London, EC1A 7BE, UK
Eur Radiol 19:1069-78. 2009..Awareness of the imaging characteristics will aid identification of the source of ACTH production and allow potentially curative surgical resection...
Differential gene expression in pituitary adenomas by oligonucleotide array analysisDamian G Morris
Department of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK
Eur J Endocrinol 153:143-51. 2005..CONCLUSIONS: Expression array analysis of pituitary adenomas using the Affymetrix GeneChip HG-U133A arrays appears to be a valid method of identifying genes that may be important in tumour pathogenesis...
Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomasY Sammy Woo
Department of Endocrinology, St. Bartholomew's Hospital, London EC1A 7BE, United Kingdom
J Clin Endocrinol Metab 90:4963-9. 2005..Few patients with macroadenomas were cured by surgery. CONCLUSIONS: Pituitary macroadenomas causing Cushing's disease have biochemical features largely distinct from patients harboring microadenomas but represent one end of a continuum...
The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas)Gregory A Kaltsas
Department of Endocrinology, St. Bartholomew's Hospital, London, UK
Front Horm Res 31:61-75. 2004
Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumorsHiu Yan Chan
Barts and the London School of Medicine, London, UK
Adv Ther 27:495-511. 2010....
The role of AMP-activated protein kinase in obesityBlerina Kola
Department of Endocrinology, Barts and The London, Queen Mary s School of Medicine and Dentistry, University of London, London, UK
Front Horm Res 36:198-211. 2008..Whether AMPK changes are one of the causes or the consequence of these pathological conditions remains a matter of debate, but AMPK clearly represents a major potential pharmacological target in the treatment of these conditions...
Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma familiesSusana Igreja
Department of Endocrinology, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom EC1M 6BQ
Hum Mutat 31:950-60. 2010..Functional characterization of AIP changes is important to identify the functional impact of gene sequence variants...
Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisationMaralyn R Druce
Department of Endocrinology, Barts and the London Medical School, St Bartholomew s Hospital, London, UK
Eur J Endocrinol 162:971-8. 2010..Preoperative localisation of insulinoma improves cure rate and reduces complications, but may be challenging...
The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetesEdwin A Garcia
Department of Endocrinology, Barts and London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK
Eur J Endocrinol 161:307-15. 2009..Ghrelin and its receptor play an important role in glucose metabolism and energy homeostasis, and therefore they are functional candidates for genes carrying susceptibility alleles for type 2 diabetes...
Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndromeAndrea M Isidori
Department of Endocrinology, St. Bartholomew's Hospital, London ECIA 7BE, United Kingdom
J Clin Endocrinol Metab 88:5299-306. 2003..There does not appear to be any necessity for retaining the high-dose dexamethasone suppression test in this diagnostic work-up...
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndromeMirjam Christ-Crain
Department of Endocrinology, William Harvey Research Institute, Barts and The London, Queen Mary s School of Medicine, London EC1M 6BQ, UK
FASEB J 22:1672-83. 2008..Our data suggest that metformin treatment could be effective in preventing the metabolic complications of chronic glucocorticoid excess...
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngiomaAnthony P Goldstone
Department of Endocrinology, St Bartholomew s Hospital, London, United Kingdom
J Clin Endocrinol Metab 90:2681-90. 2005....
Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosisHelen L Storr
Department of Endocrinology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, West Smithfield, London, United Kingdom EC1A 7BE
J Clin Endocrinol Metab 89:3818-20. 2004..In conclusion, female preponderance of CD in adult patients was not present in childhood. In patients 18 yr of age or younger, there was no difference in the severity of hypercortisolemia or ACTH at diagnosis between males and females...
CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas)Anju Sahdev
Department of Radiology, St Bartholomew s Hospital, West Smithfield, London, EC1A 7BE, UK
Eur Radiol 15:85-92. 2005....
Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathwayAlexandra M Nanzer
Department of Endocrinology, St Bartholomew s Hospital, 59 Bartholomew Close, Unit 1 1, London EC1A 7BE, UK
Eur J Endocrinol 151:233-40. 2004..However, ghrelin has also been shown to have anti-proliferative effects on breast, lung and thyroid cell lines. We therefore examined the effect of ghrelin on the rat pituitary cell line GH3...
Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistanceAnthony P Goldstone
Department of Endocrinology, St Bartholomew s Hospital, London, United Kingdom EC1A 7BE
J Clin Endocrinol Metab 89:1718-26. 2004..The hyperghrelinemia in PWS adults is therefore not solely explained by their reduced visceral adiposity and relative hypoinsulinemia. Its cause and consequences await further elucidation...
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumoursGregory Kaltsas
Department of Endocrinology, St Bartholomew's Hospital, London ECIA 7BE, UK
Eur J Endocrinol 151:15-27. 2004....
Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic reviewDorota Dworakowska
Barts and the London School of Medicine, Centre for Endocrinology, London EC1M 6BQ, UK
Endocr Relat Cancer 16:45-58. 2009....
Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesisMaria Gueorguiev
Centre for Endocrinology, Barts and the London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
Pituitary 12:245-55. 2009..We review and assess the role of the beta-catenin signaling pathway in the pathogenesis of pituitary adenomas...
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanismsSimona Grozinsky-Glasberg
Barts and the London School of Medicine, Centre for Endocrinology, University of London, London EC1M 6BQ, UK
Endocr Relat Cancer 15:701-20. 2008..The development of new SSA, new drug combination therapies and chimaeric molecules should further improve the clinical management of these patients, as should a more complete understanding of their mode of action...
Dynamic testing in Cushing's syndromeBlerina Kola
Department of Endocrinology, Barts and The London, Queen Mary s School of Medicine, University of London, London, UK
Pituitary 11:155-62. 2008..The biochemical results should be interpreted jointly with the clinical aspects and the radiology findings in a probabilistic matrix, and not as part of a uniform algorithm...
123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlationKunwar S S Bhatia
Department of Academic Radiology, St Bartholomew s Hospital, London, UK
Clin Endocrinol (Oxf) 69:181-8. 2008..Evidence regarding the accuracy of [(123)I] metaiodobenzylguanidine (MIBG) imaging for phaeochromocytoma localization is currently limited to small series...
Insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemiaPartha Kar
Department of Medicine, Great Western Hospital, Swindon, UK
J Clin Endocrinol Metab 91:4733-6. 2006..CONCLUSIONS: Although the sensitivity of the 72-h fast is high and still plays an important role in the diagnosis of an insulinoma, we suggest that a "normal" test result should be interpreted in the light of clinical symptoms...
Retinoic acid as a novel medical therapy for Cushing's disease in dogsVictor Castillo
, Hospital Escuela, Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, 1428 Buenos Aires, Argentina
Endocrinology 147:4438-44. 2006..This study highlights the possibility of using retinoic acid as a novel therapy in the treatment of ACTH-secreting tumors in humans with Cushing's disease...
The diagnosis and management of malignant phaeochromocytoma and paragangliomaAlexandra Chrisoulidou
Department of Endocrinology and Endocrine Oncology, Theagenion Hospital, Thessaloniki, Greece
Endocr Relat Cancer 14:569-85. 2007..Ongoing microarray studies may provide novel intracellular pathways of importance for proliferation/cell cycle control, and lead to the development of novel pharmacological agents...
The optimal imaging of adrenal tumours: a comparison of different methodsIoannis Ilias
Department of Endocrinology, Elena Venizelou Hospital, Athens GR 11521, Greece
Endocr Relat Cancer 14:587-99. 2007..Adrenal imaging complements and assists the clinical and hormonal evaluation of adrenal tumours...
Cushing's disease in children and adolescents: 20 years of experience in a single neurosurgical centerShabin M Joshi
Department of Neurosurgery, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London, England
Neurosurgery 57:281-5; discussion 281-5. 2005..We found the use of intraoperative neuronavigation to be an excellent aid in overcoming such anatomic difficulties...
Osteoporosis in Cushing's syndromeGregory Kaltsas
Department of Endocrinology, St Bartholomew's Hospital, London, UK
Front Horm Res 30:60-72. 2002
Pituitary-targeted medical therapy of Cushing's diseaseKrystallenia I Alexandraki
Professor of Neuroendocrinology St Bartholomew s Hospital, Ashley Grossman FMedSci, London EC1A 7BE, UK
Expert Opin Investig Drugs 17:669-77. 2008..However, no effective drug that directly and reliably targets the adrenocorticotropin-secreting pituitary adenoma has yet been found...
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinaseBlerina Kola
Department of Endocrinology, William Harvey Research Institute, Barts and the London Medical School, London EC1M 6BQ, United Kingdom
J Biol Chem 280:25196-201. 2005..Our data demonstrate that AMPK not only links the orexigenic effects of endocannabinoids and ghrelin in the hypothalamus but also their effects on the metabolism of peripheral tissues...
A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemiaFarideh Miraki-Moud
Department of Endocrinology, 51-53 Bartholomew Close, St. Bartholomew's Hospital, London EC1A 7BE, United Kingdom
J Clin Endocrinol Metab 90:3819-23. 2005....
Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell LineSimona Grozinsky-Glasberg
Department of Endocrinology, William Harvey Research Institute, Barts and The London, Queen Mary s School of Medicine and Dentistry, University of London, London, UK
Neuroendocrinology 87:168-81. 2008..We explored the mechanism of action of octreotide, RAD001, and their combination on cell proliferation and kinase activation in a neuro-endocrine tumour cell line (rat insulinoma cell line, INS1)...
The heme oxygenase-carbon monoxide pathway in the control of neuroendocrine functionPierluigi Navarra
Institute of Pharmacology, Catholic University Medical School, Rome, Italy
Front Horm Res 29:108-16. 2002
The 2004 World Health Organization classification of pituitary tumors: is it clinically helpful?Ashley B Grossman
Acta Neuropathol 111:76-7. 2006
Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable diseaseC Megan Ogilvie
Department of Endocrinology, St. Bartholomew's Hospital, London, EC1A 7BE, UK
Pituitary 8:139-46. 2005..This is an important diagnosis to make as rapidly as possible to allow the early institution of effective therapy...
Cushing's syndromeJohn Newell-Price
Division of Clinical Sciences, University of Sheffield, Northern General Hospital, Sheffield, UK
Lancet 367:1605-17. 2006..Here, we review the current understanding of pathogenesis, clinical features, diagnostic, and differential diagnostic approaches. We provide diagnostic algorithms and recommendations for management...
The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid systemBlerina Kola
Department of Endocrinology, Barts and the London School of Medicine and Dentistry, University of London, United Kingdom
PLoS ONE 3:e1797. 2008..The cannabinoid receptor type 1 (CB1) antagonist rimonabant can block the orexigenic effect of ghrelin. In this study, we have elucidated the mechanism of the putative ghrelin-cannabinoid interaction...
Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005Karel Pacak
National Institute of Child Health and Development, NIH, Bethesda, MD, USA
Nat Clin Pract Endocrinol Metab 3:92-102. 2007..Inadequate methods to distinguish malignant from benign tumors and a lack of effective treatments for malignancy are important problems requiring further resolution...
Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advancesHelen L Storr
Department of Endocrinology, William Harvey Research Institute, Barts and The London, Queen Mary s School of Medicine and Dentistry, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK
Trends Endocrinol Metab 18:167-74. 2007..The management of paediatric CS patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulatorNikolai Petrovsky
Autoimmunity Research Unit, The Canberra Hospital, John Curtin School of Medical Research, Australian National University, Canberra, Australia
Immunol Cell Biol 81:137-43. 2003..These observations explain the beneficial role of macrophage migration inhibitory factor neutralization in models of inflammatory arthritis...
Adrenal incidentalomas: 'the rule of four'Krystallenia I Alexandraki
Department of Endocrinology, St Bartholomew's Hospital, London
Clin Med 8:201-4. 2008
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibilityDewi Astuti
Section of Medical and Molecular Genetics, Department of Paediatrics and Child Health, University of Birmingham, Edgbaston, Birmingham, UK
Clin Endocrinol (Oxf) 59:728-33. 2003..CONCLUSION: The significantly lower frequency (P = 0.028) of germline SDH subunit mutations in familial PC only cases compared to those with familial PC and HNPGL suggests that further PC susceptibility gene(s) remain to be identified...
